For example, mutations in the SWI/SNF components ARID1A and PBRM1 are especially prevalent in bladder48 and renal49 cancers, and tumours harbouring these mutations may have dependencies on other SWI/SNF components that can be therapeutically exploited50. Here, ARID1A is linked to neoplasm.